• 1
    Hock JM 2001 Anabolic actions of PTH in the skeletons of animals. J Musculoskel Neuron Interact 2:3347.
  • 2
    Rubin MR, Cosman F, Lindsay R, Bilezikian JP 2002 The anabolic effects of parathyroid hormone. Osteoporos Int 13:267277.
  • 3
    Cosman F, Lindsay R 1998 Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence. Calcif Tissue Int 62:475480.
  • 4
    Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F 1997 Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350:550555.
  • 5
    Sato M, Westmore M, Clendenon J, Smith S, Hannum B, Zeng GQ, Brommage R, Turner CH 2000 Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques. Osteoporos Int 11:871880.
  • 6
    Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:14341441.
  • 7
    Bagi CM, Wilkie D, Georgelos K, Williams D, Bertolini D 1997 Morphological and structural characteristics of the proximal femur in human and rat. Bone 21:261267.
  • 8
    Turner CH, Burr DB 1993 Basic biomechanical measurements of bone: A tutorial. Bone 14:595608.
  • 9
    Hesp R, Hulme P, Williams D, Reeve J 1981 The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34). Metab Bone Dis Relat Res 2:331334.
  • 10
    Burr DB, Hirano T, Turner CH, Hotchkiss C, Brommage R, Hock JM 2001 Intermittently administered human parathyroid hormone(1–34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 16:157165.
  • 11
    Turner CH 2002 Biomechanics of bone: Determinants of skeletal fragility and bone quality. Osteoporos Int 13:97104.
  • 12
    Jerome CP, Peterson PE 2001 Nonhuman primate models in skeletal research. Bone 29:16.
  • 13
    Brommage R, Hotchkiss CE, Lees CJ, Stancill MW, Hock JM, Jerome CP 1999 Daily treatment with human recombinant parathyroid hormone-(1–34), LY333334, for 1 year increases bone mass in ovariectomized monkeys. J Clin Endocrinol Metab 84:37573763.
  • 14
    Jerome CP, Burr DB, Van Bibber T, Hock JM, Brommage R 2001 Treatment with human parathyroid hormone (1–34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 28:150159.
  • 15
    Uusi-Rasi K, Beck TJ, Oreskovic TL, Sato M, Bogado CE, Zanchetta JR 2002 Teripratide [rhPTH(1–34)] improves the structural geometry of the hip. J Bone Miner Res 17:S1;S208.
  • 16
    Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL 2003 Effects of teriparatide [recombinant human parathyroid hormone (1–34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 18:539543.
  • 17
    Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ 1997 Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 100:14751480.
  • 18
    Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ 2000 Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27:687694.
  • 19
    Boivin GY, Meunier PJ 2002 Effects of bisphosphonates on matrix mineralization. J Musculoskel Neuron Interact 2:538543.
  • 20
    Currey JD 1969 Mechanical consequences of varying the mineral content of bone. J Biomech 2:111.
  • 21
    Paschalis EP, Burr DB, Mendelsohn R, Hock JM, Boskey AL 2003 Bone mineral and collagen quality in humeri of ovariectomized cynomolgus monkeys given rhPTH(1–34) for 18 months. J Bone Miner Res 18:769775.
  • 22
    Jerome CP, Johnson CS, Vafai HT, Kaplan KC, Bailey J, Capwell B, Fraser F, Hansen L, Ramsay H, Shadoan M, Lees CJ, Thomsen JS, Mosekilde L 1999 Effect of treatment for 6 months with human parathyroid hormone (1–34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 25:301309.
  • 23
    Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study. J Bone Miner Res 16:18461853.
  • 24
    Jiang Y, Zhao J, Eriksen EF, Wang O, Genant HK, Mitlak BH 2002 Improved 3D microstructure of cancellous and cortical bone in a multicenter, double-blind, randomized and placebo controlled study of teriparatide (rhPTH(1–34)). J Bone Miner Res 17:S1;S135.
  • 25
    Dempster DW 2002 The impact of bone turnover and bone-active agents on bone quality: Focus on the hip. Osteoporos Int 13:349352.
  • 26
    Hirano T, Burr DB, Cain RL, Hock JM 2000 Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1–34). Calcif Tissue Int 66:456460.
  • 27
    Mashiba T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM 2001 Effects of human parathyroid hormone (1–34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits. Bone 28:538547.
  • 28
    Ishizuya T, Uzawa T, Takao R, Hori M, Yamaguchi A 1991 Parathyroid hormone inhibits differentiation of bone marrow adipocytes. J Bone Miner Res 14:S1;S209.
  • 29
    Ma L, Westmore M, Turner CH, Hock J, Vahle J, Sato M 2001 Dramatic skeletal effects of PTH in male and osteopenic ovariectomized rats after 1 year of subcutaneous administration. J Bone Miner Res 16:S1;S292.